phase i study of ziftomenib with venetoclax or venetoclax/azacitidine or 7 3 in r/r aml

Published 1 year ago • 88 plays • Length 1:12

Download video MP4
Download video MP3

Similar videos

2:11

update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
1:59

phase i study of pevonedistat, azacitidine, and venetoclax in patients with r/r aml
1:39

update on a phase i/ii study of ziftomenib in patients with r/r aml
3:40

phase ii study of venetoclax and azacitidine vs induction chemotherapy in fit patients with aml
3:22

phase i/ii study of milademetan plus low-dose cytarabine with or without venetoclax in r/r aml
1:19:05

hematology: leukocytes development, kinetics and functions (part 1) - granulocytes
8:16

cancer rounds|| knowledge series ||topic acute myeloid leukemia || dr rahul bhargava, dm hematology
4:44

7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
5:36

venetoclax and azacitidine in mds patients
2:44

phase ib/ii study of magrolimab in combination with azacitidine and venetoclax in patients with aml
2:08

inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial
3:52

venetoclax & aml
3:15

overview of a phase ib study of venetoclax and obinutuzumab in cll
4:03

a phase i/ii study evaluating quizartinib plus decitabine and venetoclax in flt3-mutated aml
1:35

phase i study of plx51107, a novel bet inhibitor, in combination with azacitidine in r/r mds and aml
5:31

the role of venetoclax in older patients with aml
2:07

analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
2:07

phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
1:52

evaluating the efficacy of obinutuzumab, ibrutinib, and venetoclax in richter's transformation
1:52

results of phase i study of mcl-1 inhibition with azd5991 in r/r hematologic malignancies
4:22

the role of mrd in aml

Clip.africa.com - Privacy-policy